北方药学
北方藥學
북방약학
JOURNAL OF NORTH PHARMACY
2015年
5期
122-122,123
,共2页
参芎葡萄糖注射液%急性脑梗死%银杏叶提取物注射液%疗效与安全性
參芎葡萄糖註射液%急性腦梗死%銀杏葉提取物註射液%療效與安全性
삼궁포도당주사액%급성뇌경사%은행협제취물주사액%료효여안전성
Shenxiong Glucose Injection%ACI%Extract Of Ginkgo Biloba Leaves Injection%Curative Effect&Safety
目的:观察临床治疗急性脑梗死使用参芎葡萄糖注射液联合银杏叶提取物注射液的效果及安全性。方法:采用随机数字表法将64例急性脑梗死患者分为观察组与对照组,每组32例。对照组单独使用银杏叶提取物注射液治疗,观察组采用联合用药治疗方式(参芎葡萄糖注射液+银杏叶提取物注射液),对比两组的治疗效果与不良反应。结果:治疗后观察组血液流变学各项指标均较稳定,相关指标水平低于对照组(P<0.05);两组患者的神经功能损伤评分均有所降低,观察组整体情况更佳(P<0.05);两组不良反应发生率比较无明显差异(P>0.05)。结论:临床治疗急性脑梗死给予这两种药物联合使用,治疗效果及安全性均较高,值得推广。
目的:觀察臨床治療急性腦梗死使用參芎葡萄糖註射液聯閤銀杏葉提取物註射液的效果及安全性。方法:採用隨機數字錶法將64例急性腦梗死患者分為觀察組與對照組,每組32例。對照組單獨使用銀杏葉提取物註射液治療,觀察組採用聯閤用藥治療方式(參芎葡萄糖註射液+銀杏葉提取物註射液),對比兩組的治療效果與不良反應。結果:治療後觀察組血液流變學各項指標均較穩定,相關指標水平低于對照組(P<0.05);兩組患者的神經功能損傷評分均有所降低,觀察組整體情況更佳(P<0.05);兩組不良反應髮生率比較無明顯差異(P>0.05)。結論:臨床治療急性腦梗死給予這兩種藥物聯閤使用,治療效果及安全性均較高,值得推廣。
목적:관찰림상치료급성뇌경사사용삼궁포도당주사액연합은행협제취물주사액적효과급안전성。방법:채용수궤수자표법장64례급성뇌경사환자분위관찰조여대조조,매조32례。대조조단독사용은행협제취물주사액치료,관찰조채용연합용약치료방식(삼궁포도당주사액+은행협제취물주사액),대비량조적치료효과여불량반응。결과:치료후관찰조혈액류변학각항지표균교은정,상관지표수평저우대조조(P<0.05);량조환자적신경공능손상평분균유소강저,관찰조정체정황경가(P<0.05);량조불량반응발생솔비교무명현차이(P>0.05)。결론:림상치료급성뇌경사급여저량충약물연합사용,치료효과급안전성균교고,치득추엄。
Objective:To study the clinical effect and safety of Shenxiong glucose injection combined with extract of Ginkgo biloba leaves injection for ACI. Method:64 ACI patients were randomly divided into observation group and control group, 32 cases each group. The control group took the extract of Ginkgo biloba leaves injection;observation group combined Shenxiong glucose injection with the extract of Ginkgo biloba leaves injection. The treatment effect and adverse reactions of two groups were compared. Result:The index of hemorheology of observation group was stably lower than that of control group (P<0.05). The neurologic severity scores of two groups were reduced; the scores of observation group were better than that of control group (P<0.05); the incidence of adverse reactions was compared (P>0.05).Conclusion: The combined therapy has a higher effect and safety in clinical therapy. It is worthy of clinical promotion and application.